# CLONAZEPAM

NDC: 62332-367
Generic name: CLONAZEPAM
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20190701

FDA application: ANDA211033

## Active ingredients

- CLONAZEPAM: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-367"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-367
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ecb28fcb-f0d1-4558-b460-ecabd0f6009e